Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Th2-skewed T cells correlate with B cell response to α-Gal and tick antigens in α-Gal syndrome
Danijela Apostolovic, … , Staffan Paulie, Marianne van Hage
Danijela Apostolovic, … , Staffan Paulie, Marianne van Hage
Published January 26, 2023
Citation Information: J Clin Invest. 2023;133(6):e158357. https://doi.org/10.1172/JCI158357.
View: Text | PDF
Research Article Immunology

Th2-skewed T cells correlate with B cell response to α-Gal and tick antigens in α-Gal syndrome

  • Text
  • PDF
Abstract

Tick bites have been shown to transmit a novel form of severe food allergy, the galactose-α-1,3-galactose (α-Gal) syndrome (AGS). Cellular responses to α-Gal in patients with AGS have, to date, not been thoroughly scrutinized. Therefore, we investigated T and B cell proliferation, activation, and cytokine profiles in response to tick protein extract (TE) and α-Gal-free TE in patients with AGS and in healthy controls. T and B cells from both patients and controls proliferated in response to TE, but significantly more in patients with AGS. B cell proliferation, but not T cell proliferation, in patients with AGS was reduced by removing α-Gal from the TE. In addition, TE induced a clear Th2 cytokine profile in patients with AGS. Expression of CD23 by B cells correlated only to T cell proliferation. However, both B cell proliferation and CD23 expression were reduced when CD40L and IL-4 were blocked. A large portion of the IgG1 and IgE antibodies binding TE in patients with AGS were directed against the α-Gal epitope. We have, for what we believe to be the first time, investigated T and B cell responses to α-Gal carrying tick proteins in patients with AGS, which will be essential for the understanding of the immune response against an allergenic carbohydrate transmitted by ticks.

Authors

Danijela Apostolovic, Jeanette Grundström, Mensiena B. Gea Kiewiet, Marija Perusko, Carl Hamsten, Maria Starkhammar, Staffan Paulie, Marianne van Hage

×

Figure 1

T cell proliferation measured by dilution of CFSE.

Options: View larger image (or click on image) Download as PowerPoint
T cell proliferation measured by dilution of CFSE.
(A) Gating strategy f...
(A) Gating strategy for proliferation of CD4+ T helper cells. (B) T cell proliferation in response to different doses of TE in patients with AGS, Friedman test with Dunn’s multiple comparisons test, **P < 0.01, n = 13. (C) T cell proliferation to TE compared with unstimulated cells in patients with AGS (left, n = 35) and healthy controls (right, n = 16), Wilcoxon matched-pairs signed rank test, **P < 0.01, ***P < 0.001. (D) Comparison of patients with AGS and healthy controls, Mann-Whitney U test, *P < 0.05, n = 35 (AGS) and n = 13 (controls). (E) T cell proliferation after removal of α-Gal from the TE in patients with AGS (left, n = 10) and healthy controls (right, n = 13), Wilcoxon matched-pairs signed rank test. (F) T cell proliferation to an α-Gal containing nontick protein in patients with AGS, Wilcoxon matched-pairs signed rank test, *P < 0.05, n = 14. Each point within the box plot represents 1 individual. Box plots represent IQR and median, whiskers extend to the farthest data points.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts